In addition, high LOXL2 protein expression has been found to associate with poorer overall survival in gastric cancer [89], laryngeal squamous cell carcinoma [87], and breast cancer [90]. The gene discussed is LOXL2; the disease is laryngeal squamous cell carcinoma.